Lacosamide adjunctive therapy for uncontrolled partial-onset seizures in Japanese and Chinese adults

Phase 3, randomised, double-blind trial in epilepsy, Focal Onset Epilepsy and Focal onset seizure comparing Vimpat adjunctive therapy with Placebo adjunctive therapy (2 arms). Primary endpoint: Change in partial-onset seizure frequency per 28 days from baseline to the maintenance period.